Cocrystal Pharma Inc. (COCP)
NASDAQ: COCP
· Real-Time Price · USD
1.44
-0.02 (-1.37%)
At close: Sep 11, 2025, 3:57 PM
1.44
0.00%
After-hours: Sep 11, 2025, 05:29 PM EDT
-1.37% (1D)
| Bid | 1.44 |
| Market Cap | 14.76M |
| Revenue (ttm) | 136K |
| Net Income (ttm) | -12.56M |
| EPS (ttm) | -1.24 |
| PE Ratio (ttm) | -1.16 |
| Forward PE | -1.91 |
| Analyst | Buy |
| Ask | 1.55 |
| Volume | 21,644 |
| Avg. Volume (20D) | 76,429 |
| Open | 1.47 |
| Previous Close | 1.46 |
| Day's Range | 1.43 - 1.47 |
| 52-Week Range | 1.12 - 3.26 |
| Beta | 2.28 |
About COCP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COCP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COCP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+9.09%
Cocrystal Pharma shares are trading higher after t...
Unlock content with
Pro Subscription
8 months ago
+6.64%
Cocrystal Pharma shares are trading higher after the company announced Phase 1 results for its oral broad-acting antiviral drug CDI-988.
